Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

We have observed 6 EP applications Jan Peter Storm has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 14, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12785416

A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS

IPC classification:
C07D 317/44, C07B 57/00
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12735323

N- (6- ( (2R,3S) -3,4-DIHYDROXYBUTAN-2-YLOXY) -2- (4 - FLUOROBENZYLTHIO) PYRIMIDIN- 4 - YL) -3- METHYLAZETIDINE- 1 - SULFONAMIDE AS CHEMOKINE RECEPTOR MODULATOR

IPC classification:
A61K 31/506, C07D 403/12, C07D 317/24, C07D 317/20, C07D 205/04, C07C 69/92
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED
EP12722808

PROCESS

IPC classification:
C07D 498/10, C07D 277/68, C07C 309/08
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753340

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

IPC classification:
A61K 47/48, C07D 217/04, A61P 13/12, A61P 9/12, A61P 9/04, A61P 1/00
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
The patent has been granted
EP13753904

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

IPC classification:
A61K 47/48, A61P 13/12, A61P 9/12, A61P 9/04, A61P 1/00
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP15736015

BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS

IPC classification:
A61P 9/12, A61K 31/538, C07D 265/36
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature